Australia sues 3M for up to $2bn over 'forever chemicals' at defense sites
The Australian government launched legal action against the US industrial conglomerate 3M on 28 May 2026, filing a Federal Court claim seeking up to $2bn in remediation costs for PFAS contamination at dozens of defence installations. The lawsuit, lodged by the Attorney-General's Department on behalf of the Commonwealth, names 3M as the manufacturer of aqueous film-forming foam (AFFF) — a firefighting agent widely used at Australian military airfields from the 1970s until its gradual phase-out — and alleges the company knew of environmental and health risks associated with the chemicals for decades before restricting their use.
The claim puts 3M's AustralianPFAS liabilities on a collision course with the company's global settlement architecture. Since 2020, 3M has paid more than $10bn to settle US state and municipal PFAS claims. The Australian case is structurally similar but legally distinct — governed by Commonwealth environmental law, referencing a different regulatory framework, and targeting a narrower set of contaminated sites. The government has not yet disclosed its precise damage calculation, but the $2bn quantum reflects estimated remediation costs across at least 62 identified Defence Department locations, including RAAF bases at Williamtown in New South Wales, Darwin in the Northern Territory, and East Sale in Victoria — areas where groundwater and soil contamination has been confirmed well beyond base boundaries into surrounding farmland and residential zones.
What PFAS are, and why they are different
PFAS — per- and polyfluoroalkyl substances — are a family of synthetic compounds developed in the 1940s for their resistance to heat, oil, water, and stains. Those properties made them ideal for a range of commercial applications: non-stick cookware coatings, food packaging, waterproof textiles, and, crucially for Defence purposes, firefighting foam that suppresses fuel fires more effectively than water alone. The compounds are extraordinarily stable. PFAS do not break down in the natural environment under normal conditions — a characteristic that earned them the "forever chemical" label. They accumulate in human tissue, persisting for years after exposure, and epidemiological studies have associated certain PFAS compounds with immune system disruption, liver enzyme abnormalities, thyroid disease, and elevated risks of kidney and testicular cancers.
Regulatory responses globally have tightened substantially over the past decade. The United States Environmental Protection Agency issued updated health advisories in 2022 establishing near-zero concentration thresholds for PFAS in drinking water. The European Union is advancing a comprehensive PFAS restriction under its REACH chemical regulation framework. Canada, New Zealand, and Germany have each initiated multi-billion-dollar remediation programmes at former military installations. Australia's own PFAS management framework has been in place since 2016, administered by the Department of Defence, but funding for full remediation has been contingent on securing compensation — hence the litigation.
The science, the litigation, and what 3M disputes
The legal argument is straightforward in outline if not in evidentiary detail: 3M manufactured and supplied AFFF to Australian Defence facilities over a period of approximately 40 years; PFAS compounds in that foam migrated from base infrastructure into surrounding soil and groundwater; those compounds are now classified as hazardous substances under Australian environmental law; and 3M bears responsibility for the remediation costs the Commonwealth has incurred and continues to incur.
3M has acknowledged PFAS presence at some Australian Defence sites. The company's position, expressed in prior Australian parliamentary testimony, is that the science on human health impacts was evolving throughout the period of use, that regulatory guidance at the time did not mandate restrictions, and that the Commonwealth itself exercised operational control over the foam and its disposal. The company further argues that Australian courts should not apply retrospective liability standards derived from post-hoc scientific consensus to assess historical conduct.
That dispute — science applied retroactively versus corporate responsibility for known or foreseeable harms — will sit at the centre of the Federal Court proceedings. It is not unique to Australia. The US litigation turned on parallel questions of corporate knowledge: internal 3M documents unsealed during discovery revealed that company scientists flagged PFAS bioaccumulation risks as early as the 1970s, a fact that influenced settlement negotiations in American cases. Australian litigators are likely to seek discovery of comparable documents under bilateral evidence-sharing arrangements.
A global template, not an isolated case
Australia's action sits inside a broader international pattern. PFAS litigation has matured from a US phenomenon into a coordinated global campaign. The EU, Canada, and New Zealand each maintain active proceedings or have concluded settlements with 3M, DuPont, and other PFAS manufacturers. The Australian government is watching the outcomes of those cases closely — not least because the legal architecture, once tested in a Commonwealth court, could serve as a template for coordinated action by a coalition of affected nations. That would amplify pressure on 3M and its peers and could shift the calculus of any eventual global settlement.
For Canberra, the stakes are financial and institutional. The Defence Department has spent several hundred million dollars on containment, monitoring, and preliminary remediation at affected sites. Full remediation — replacing contaminated soil, treating groundwater plumes, rebuilding infrastructure where contamination is deepest — is estimated to cost figures in the range the government is now claiming. Without a successful judgment or negotiated settlement, those costs fall on the Australian taxpayer indefinitely. With a settlement, the liability transfers to the company and the clean-up accelerates.
The outcome will also signal something about the enforceability of environmental cost recovery against multinational corporations in Australian jurisdictions — a question that has implications well beyond PFAS. If the Federal Court finds in the Commonwealth's favour on the question of corporate knowledge, it creates a precedent that environmental lawyers expect to cite in subsequent cases involving other persistent chemical substances.
What remains uncertain
The sources do not specify the precise damage methodology the government used to arrive at the $2bn figure, nor do they confirm whether the claim encompasses all 62 identified sites or a subset. The legal proceedings are at an early stage; 3M has not yet filed a formal response to the claim, and no hearing dates have been set. The company's public statement to Reuters on 28 May described the claim as "without merit" but did not elaborate on specific grounds. It remains possible — and not unusual in complex multi-defendant environmental litigation — that 3M seeks to shift part of the liability to Defence Department contractors or to argue that Commonwealth procurement processes shared responsibility for site contamination. The resolution of those questions will determine not just the quantum of any judgment but the broader distribution of liability between the state, the manufacturer, and the supply chain.
Monexus framed this as a landmark environmental law case with institutional and geopolitical dimensions — the government is not merely seeking compensation but establishing Australian precedent for holding multinational chemical manufacturers accountable under domestic law. The wire services led with the dollar figure as spectacle; this desk considers the litigation architecture and what it signals about the global enforcement of chemical liability the more consequential frame.
Wire provenance
This editorial synthesis draws on the following public wire/social posts:
- http://reut.rs/4wTDH2L
- https://www.epa.gov/pfas